Corrigendum to ‘Allergy and anaesthesia: managing the risk’ [BJA Education 20 (2020) 298–304]

The authors regret that an error is present on page 302 in the first sentence under the heading Sugammadex. The sentence should read as follows:

‘There is current debate in the literature about the relative risk of allergy to reversal agents, with sugammadex recently demonstrated to have a risk of allergy of 1:5000 administrations in Japan.^24’

The authors would like to apologise for any inconvenience caused.

DOI of original article: 10.1016/j.bjae.2020.04.005